Subscribe to RSS Feed
Medicines-Diabetes Treatment-various-InstituteOfEPM-Bittner-Boiron-Novartis-AstraZeneca-EndoPharm-NovoNordisk-Valenta-Shering-Plau-KRKA-Sintez-Medisorb-Sandoz-PierreFabre-Kamelia-Italfarmaco-Lek-Falk Pharma-SUNpharma-UPSA-Polpharma-Adipharm-AFD-Simpex-Hyperion-Hexal-Avexima-Фармстандарт-Лексредства ОАО
Ozempic® (Semavik) 0,25/0,5/1 mg/dose solution for subcutaneous administration 3 ml syringe pen 1 pc.
Ozempic is a self-injectable medication that contains the active ingredient, semaglutide. Previously, it has been prescribed ‘off label’ for weight loss, but it is licensed in the UK for treating type 2 diabetes. Semaglutide is available as a weight loss injection under the brand name Semavik.
Medicines-Diabetes Treatment-various-InstituteOfEPM-Bittner-Boiron-Novartis-AstraZeneca-EndoPharm-NovoNordisk-Valenta-Shering-Plau-KRKA-Sintez-Medisorb-Sandoz-PierreFabre-Kamelia-Italfarmaco-Lek-Falk Pharma-SUNpharma-UPSA-Polpharma-Adipharm-AFD-Simpex-Hyperion-Hexal-Avexima-Фармстандарт-Лексредства ОАО
Currently Shopping by
- The purpose of the medication: Remove This Item Diabetes Treatment
-
Manufacturer:
various
InstituteOfEPM
Bittner
Boiron
Novartis
AstraZeneca
EndoPharm
NovoNordisk
Valenta
Shering-Plau
KRKA
Sintez
Medisorb
Sandoz
PierreFabre
Kamelia
Italfarmaco
Lek
Falk Pharma
SUNpharma
UPSA
Polpharma
Adipharm
AFD
Simpex
Hyperion
Hexal
Avexima
OTCPharm JSC
- The purpose of the medication
- Manufacturer
